Re: Arcuri and Americo "Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis"

Ann Hematol. 2022 Jul;101(7):1599-1601. doi: 10.1007/s00277-022-04792-0. Epub 2022 Feb 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bortezomib / therapeutic use
  • Dexamethasone / therapeutic use
  • Humans
  • Lenalidomide / therapeutic use
  • Multiple Myeloma* / drug therapy
  • Neoplasm Recurrence, Local / drug therapy
  • Network Meta-Analysis

Substances

  • Bortezomib
  • Dexamethasone
  • Lenalidomide